UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000047483
Receipt number R000054151
Scientific Title Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study
Date of disclosure of the study information 2022/04/15
Last modified on 2022/10/20 10:51:31

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study

Acronym

Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study

Scientific Title

Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study

Scientific Title:Acronym

Aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia: a three-arm, randomized controlled pilot and feasibility study

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate aerobic exercise versus cognitive remediation versus a combination of both in patients with schizophrenia.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Cognition

Key secondary outcomes

Intrinsic motivation
Psychiatric symptom
Functioning


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Aerobic exercise

Interventions/Control_2

cognitive remediation

Interventions/Control_3

a combination of both

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

(1) 20-60 years of age
(2) diagnosed with schizophrenia based on DSM 5

Key exclusion criteria

(1) a current primary DSM 5 diagnosis other than schizophrenia
(2) a history of mental retardation
(3) a history of neurological disorder
(4) a history of significant drug or alcohol abuse
(5) current risk of suicide, or a history of suicidal behavior within 6 months prior to consent
(6) comorbid serious physical disorder

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

386-0401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268350305

Email

ot@seitaikai.or.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Shimada

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Division name

Department of Rehabilitation

Zip code

386-0401

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

TEL

0268-35-0305

Homepage URL


Email

ot@seitaikai.or.jp


Sponsor or person

Institute

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Institute

Department

Personal name



Funding Source

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Seitaikai Mental Support Soyokaze Hospital

Address

3057-1, Shiogawa, Ueda, Nagano, Japan

Tel

0268-35-0305

Email

ot@seitaikai.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2022 Year 04 Month 15 Day

Date of IRB

2022 Year 04 Month 15 Day

Anticipated trial start date

2022 Year 04 Month 15 Day

Last follow-up date

2022 Year 07 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 04 Month 14 Day

Last modified on

2022 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000054151


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name